References

  1. Blumenthal M, Busse WR, Goldberg A, et al, eds. The Complete Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative Medicine Communications, 1998, 148–149.
  2. Murray, M.T. (1999) Horse chestnut extract in chronic venous insufficiency. Natural Medicine Online, July. http://www.nat-med.com/
  3. Vanhoutte PM, et al. (1997) Venous disease: from pathophysiology to quality of life. Angiology 48(7):559-67.
  4. Bombardelli E, et al. (1996). Aesculus hippocastanum L. Fitoterapia 67:483-511.
  5. (3737) Escin in the Merck Index, Twelfth Edition, page 628.
  6. Lorenz D, Marek ML. (1960) Das therapeutische wirksame Prinzip der Rosskastanie (Aesculus hippocastanum). Arzneim- Forsch 10:263-272.
  7. Guillaume M, Padioleau. (1994). Veinotonic effect, vascular protection, antiinflammatory and free radical scavenging properties of horse chestnut extract. Arzneim-Forsch 44:25-35.
  8. Schrader E, et al. (1995) Vergleichende Untersuchung zur Bioverfügbarkeit von ß-Aescin nach oraler Einmalverabreichung zweier Rosskastaniensamenextrakt enthaltender, galenisch unterschiedlicher Darreichungsformen. Pharmazie 50:623-627.
  9. Masaki H, et al. (1997) Effect of escins Ia, IIa, and IIb from horse chestnut, the seeds of Aesculus hippocastanum L., on acute inflammation in animals. Biol Pharm 20:1092-5.
  10. Facino RM, et al. (1995) Anti-elastase and anti-hyaluronidase activities of saponins and sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: factors contributing to their efficacy in the treatment of venous insufficiency. Arch. Pharm 328:720-24.
  11. Sarin S, et al (1993) Neutrophil activation in venous disease. J Vasc Surg 17:444.
  12. Calabrese, C. and Preston, P. (1993) Report of the results of a double-blind, randomized, single-dose trial of a topical 2% escin gel versus placebo in the acute treatment of experimentally-induced hematoma in volunteers. Planta Medica 59:394-397.
  13. Guillaume , M. and Padioleau, F. (1994) Veinotonic effect, vascular protection, anti-inflammatory and free radical scavenging properties of horse chestnut extract. Arzneim-Forsch Drug Research. 44(1): 25-35.
  14. Annoni, F. et al. (1979) Venotonic activity of escin on the human saphenous vein. Arzneimittelforschung; 29(4):672-5.
  15. Lochs H et al. (1974) Effect of horse chestnut extracts on venous tone Arzneimittelforschung Sep; 24(9):1347-50
  16. Bonati A. (1977) Les dérivès du marronnier d'Inde dans le traitment des maladies vasculaires. Plantes Méd.Phytothér. 11: 174-80.
  17. Pittler MH, Ernst E. (1998) Horse-chestnut seed extract for chronic venous insufficiency: a criteria-based systematic review. Arch Dermatol November; 134:1356-60.
  18. Apgar, B. (1999) Horse-Chestnut Seed Extract for Chronic Venous Insufficiency. American Family Physician, March 15, pp 1623.
  19. Diehm, G.et al (1996) Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency. Lancet 347(8997):292-4
  20. Rehr, D. et al. (1996) Comparative clinical efficacy and tolerability of oxerutins and horse chestnut extract in patients with chronic venous insufficiency. Arzneim-Forsch/Drug Res. 46(1):483-487.
  21. Bombardelli E., et al. (1989) "Topical Anti-Inflammatory Activity of Complexes of Escin and Sterols with Phospholipids - Part I", Fitoterapia 60, Supplemento al n. 1, 39
  22. Curri S.B., et al. (1989) "Topical Anti-Inflammatory Activity of Complexes of Escin and Sterols with Phospholipids - Part II: Anti-Oedema Properties in the Treatment of Panniculopathies of the Thighs and Breast", Fitoterapia 60, Supplemento al n. 1, 45
  23. Morgan M., and Bone K.. (1998) Aesculus hippocastanum — Horsechestnut. MediHerb Professional Review. No. 65, pp. 1-6.
  24. Hellberg K et al. (1975) Drug induced acute renal failure after heart surgery. Thoraxchir Vask Chir Aug;23(4):396-9
  25. Rothkopf M, et al. (1977) Animal experiments on the question of the renal toleration of the horse chestnut saponin aescin. Arzneimittelforschung 27(3): 598–605.
  26. Brinker F. (1998) Herb Contraindications and Drug Interactions, 2nd ed. Oregon: Eclectic Medical Publications : 84.
  27. Heck, A.M. et al (2000) Potential interactions between alternative therapies and warfarin. Am J Health-Syst Pharm. 57:1221-30
  28. Rudofsky G, Neiß A, Otto K, Seibel K. Ödemprotektive Wirkung und klinische Wirksamkeit von Roßkastaniensamenextrakt im Doppeltblindversuch. Phlebol Proktol 15:47-54, 1986.
  29. Bisler H, Pfeifer R, Klüken N, Pauschinger. Wirkung von Roßkastaniensamenextrakt auf die transkapillŠre Filtration bei chronisch venšser Insuffizienz. Dtsch med Wschr. 111:1321-29, 1986.
  30. Pilz E. Ìdeme bei Venenerkrankungen. Die Medizinische Welt 40:1143-4, 1990.
  31. Diehm C, Vollbrecht D, Amendt K, Comberg HU. Medical edema protection - Clinical benefit in patients with chronic deep vein incompetence. A placebo controlled double blind study. VASA 21:188-191, 1992.
  32. Friederich HC, Vogelsberg H, Neiss A. Ein Beitrag zur Bewertung von intern wirksamen Venenpharmaka. Z Hautkr. 53:369-74, 1978.
  33. Lohr E, Garanin G, Jesau P, Fischer H. Ödempräventive Therapie bei chronischer Veneninsuffizienz mit Ödemneigung. Münch med Wschr 128:59-81, 1986.
  34. Neiss A, Böhm C. Zum Wirksamkeitsnachweis von Roßkastaniensamenextrakt beim varikösen Symptomenkomplex. Münch med Wschr 118:213-6, 1976.
  35. Steiner M. Untersuchungen zur ödemvermindernden und ödemprotektiven Wirkung von Roßkastaniensamenextrakt. Phlebol Proktol. 19:239-42, 1990.
  36. Kalbfleisch W, Pfalzgraf H. Ödemprotektiva. Äquipotente Dosierung - Roßkastaniensamenextrakt und O-ß-Hydroxyethylrutoside im Vergleich. Therapiewoche 39:3703-7, 1989.
  37. Rehn D, Unkauf M, Klein P, Jost V, Lücker PW. Comparative clinical efficacy and tolerability of ocerutins and horse chestnut extract in patients with chronic venous insufficiency. Arzneim Forsch 46:483-7, 1996.
  38. Erdlen F. Klinische Wirksamkeit von Venostasin retard im Doppelblindversuch. Die Medizinische Welt 40:994-6, 1989.
  39. Erler M. Roßkastaniensamenextrakt bei der Therapie peripherer venöser Ödeme - ein klinischer Therapievergleich. Die Medizinische Welt. 42:593-6, 1991.
  40. Hippocastani semen (Horse-chestnut Seed) ESCOP:Monographs on the medicinal uses of plant drugs, Fascicule 6.

 

 

©  Sabinsa Corporation 2000